You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence
employee receiving a flu shot 

Dana-Farber achieves 100 percent compliance for flu vaccinations

Last fall, Dana-Farber was lauded by the Boston Globe for having the highest vaccination rate in 2013 among Massachusetts hospitals, with 99 percent of staff receiving a flu vaccine. For the 2013-14 flu season, Dana-Farber did even better — achieving 100 percent compliance for flu vaccinations. "I am very proud of our employees for continuing to embrace our efforts to bring the Institute's flu policy in line with our other safety measures for averting the spread of preventable infection," says Dana-Farber President and CEO Edward J. Benz Jr., MD. "Universal compliance should be every hospital's goal, and I am happy once again with our leadership in this area."

Dana-Farber scientists receive Stand Up To Cancer-Farrah Fawcett Foundation Grant for research in novel vaccine for HPV-associated cancers

April 07, 2014

Dana-Farber researchers have received a three-year, $1.2 million research grant from Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation to lead a team in developing and testing new vaccines for patients with cancers linked to the human papillomavirus (HPV).

Scientists find potential drug targets in deadly pediatric brain tumors
April 06, 2014

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings, published in Nature Genetics, identify potential new targets for drug treatments.

Study identifies lung cancer patients likely to benefit from potential immune system-based therapy
April 06, 2014

Investigators at Dana-Farber led by Leena Gandhi, MD, PhD, report a promising way of predicting which patients with non-small cell lung cancer (NSCLC) are most likely to benefit from a drug that frees up an immune system attack on tumor cells.

Dana-Farber Cancer Institute and Steward St. Elizabeth’s Medical Center join to provide integrated cancer care
March 31, 2014

Beginning this summer, Dana-Farber Cancer Institute will provide hematology and medical oncology care under a new agreement at St. Elizabeth's Medical Center, a part of the Steward Health Care System.

Elizabeth Warren Calls for More Federal Research Money (BU Today)

April 16, 2014

At a meeting with Senator Elizabeth Warren, Dr. Barrett Rollins warned that young researchers were abandoning the field or taking jobs in more research-generous countries.

Immunotherapy Passes Early Tests in NSCLC (MedPage Today)
April 10, 2014

Dr. Leena Gandhi reported at the AACR meeting on a study showing a cancer immunotherapy that passed a key test in patients with lung cancer.

Breast Cancer's Racial Divide (WCVB-TV 5 Boston)
April 08, 2014

Dana Farber’s Mammography Van and patient advocates are helping to ensure that women in minority communities are getting cancer screenings.

Breast Cancer Drug Results As Impressive As I've Ever Seen Researcher Says (NY Times)
April 06, 2014

Dr. Judy Garber and Dr. Eric Winer commented on an experimental medicine that has slowed the pace of advanced breast cancer, doubling the amount of time that patients could live without their tumors advancing.

Cancer between the Lines Video Project for Young Adults

April 28, 2014

1:00 PM - 5:00 PM

Dana Building, Lower Level


Young adults coping with cancer can face a variety of challenges, including communicating with their caregivers. The Young Adults Program at Dana-Farber invites young adult patients to share the aspects of human connection that play a role in the experience of cancer. "Cancer between the Lines" will provide a platform to recognize, honor, and share the unique narratives of young adult patients and their caregivers at Dana-Farber. Patients and their primary or medical caregivers can participate in recorded conversations. For more information or to reserve a spot, call 617-632-6819 or email



Artful Healing Program

April 21, 2014

11:00 AM - 1:00 PM

Blum Resource Center, Yawkey Center, Floor 1

Leonard P. Zakim Center and Boston Museum of Fine Arts presents: Artful Healing Program

Join us for inspiring workshops by experienced art educators from the Museum of Fine Arts, Boston.
The workshops give participants an opportunity to “explore” the MFA through viewing a slideshow of a collection of MFA pieces and
then participating in a hands-on activity related to what they have seen.


For more information and to register, please contact the Zakim Center at 617-632-3322 or at  You may also visit us at


Thriving with Yoga(4)

April 21, 2014

5:30 PM - 6:30 PM

Elliot Regional Cancer Center, 40 Buttrick Road, Londonderry

Presented in cooperation with YogaCaps, Inc.  Open to those with a current or past cancer diagnosis.  Beginners or those experienced in yoga are welcome. Caregivers may also attend.

This program is free.  Please call 603-670-0302 to register, as space may be limited. 


Dana-Farber's Mammography Van(26)

April 22, 2014

9:00 AM - 3:00 PM

The Dimock Center

 Our experts offer mammograms to women 40 years of age and older. For more information or to make an appointment, call Dana-Farber's Mammography Van office during regular business hours 9:00 a.m. – 5:30 p.m. at 617-632-1974 or e-mail


  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    For children:

    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now